Envision Inc. Files Q1 2025 10-Q

TL;DR

Envision Inc. 10-Q filed. Financials for Q1 2025 are in. Check it out.

AI Summary

Envision Inc. filed its 10-Q for the period ending June 30, 2025, reporting financial results. The company, formerly known as Electros Cope Inc., is based in Boulder, Colorado, and operates in the surgical and medical instruments sector. Specific financial figures for the quarter and year-to-date are detailed within the filing.

Why It Matters

This filing provides investors with the latest financial performance data for Envision Inc., crucial for understanding the company's current health and future prospects in the medical device market.

Risk Assessment

Risk Level: medium — The risk level is medium due to the nature of SEC filings which can contain forward-looking statements and financial performance details that may impact stock valuation.

Key Numbers

• 20250630 — Reporting Period End Date (Indicates the end of the fiscal quarter for which financial information is reported.)
• 20250815 — Filing Date (The date the 10-Q report was officially submitted to the SEC.)
• 2025-04-01 to 2025-06-30 — Current Quarter (The specific period covered by the financial statements in this filing.)
• 2024-04-01 to 2024-06-30 — Prior Year Quarter (Provides a comparative period for financial analysis.)

Key Players & Entities

• ENCISION INC (company) — Filer
• ELECTROSCOPE INC (company) — Former company name
• 3841 (dollar_amount) — Standard Industrial Classification Code
• CO (company) — State of Incorporation
• 0331 (dollar_amount) — Fiscal Year End
• 001-11789 (dollar_amount) — SEC File Number
• 251222101 (dollar_amount) — Film Number
• 6797 WINCHESTER CIRCLE (dollar_amount) — Business Street Address
• BOULDER (dollar_amount) — Business City
• CO (dollar_amount) — Business State

FAQ

Filing Documents

• ecia_10q-063025.htm (10-Q) — 437KB
• ex31x1.htm (EX-31.1) — 11KB
• ex31x2.htm (EX-31.2) — 12KB
• ex32x1.htm (EX-32.1) — 7KB
• 0001079973-25-001326.txt ( ) — 3042KB
• ecia-20250630.xsd (EX-101.SCH) — 19KB
• ecia-20250630_cal.xml (EX-101.CAL) — 38KB
• ecia-20250630_def.xml (EX-101.DEF) — 61KB
• ecia-20250630_lab.xml (EX-101.LAB) — 216KB
• ecia-20250630_pre.xml (EX-101.PRE) — 180KB
• ecia_10q-063025_htm.xml (XML) — 375KB

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 11 ITEM 3 -

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 16 ITEM 4 -

Controls and Procedures

Controls and Procedures 17 PART II. OTHER INFORMATION 18 ITEM 1 -

Legal Proceedings

Legal Proceedings 18 ITEM 1A -

Risk Factors

Risk Factors 18 ITEM 2 - Unregistered Sales of Equity Securities and Use of Proceeds 18 ITEM 3 - Defaults Upon Senior Securities 18 ITEM 4 - Mine Safety Disclosures 19 ITEM 5 - Other Information 19 ITEM 6 - Exhibits 19

FINANCIAL INFORMATION

PART I FINANCIAL INFORMATION ITEM 1 - Condensed Interim Financial Statements Encision Inc. Condensed Balance Sheets June 30, 2025 March 31, 2025 Unaudited Audited ASSETS Current assets: Cash $ 47,918 $ 257,433 Accounts receivable 749,426 786,471 Inventories 1,534,887 1,483,182 Prepaid expenses 118,308 85,679 Total current assets 2,450,539 2,612,765 Equipment: Furniture, fixtures, and equipment, at cost 2,591,981 2,585,446 Accumulated depreciation ( 2,358,134 ) ( 2,340,689 ) Equipment, net 233,847 244,757 Right of use asset, net 1,199,806 568,395 Patents, net 166,708 171,890 Other assets 80,655 72,892 TOTAL ASSETS 4,131,555 3,670,699 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Accounts payable $ 328,123 $ 346,900 Line of credit 320,440 395,964 Secured notes 39,802 44,128 Accrued compensation 208,850 180,850 Deferred Revenue 2,574 17,401 Other accrued liabilities 129,615 160,274 Accrued lease liability 248,469 430,398 Total current liabilities 1,277,873 1,575,915 Long-term liability: Secured notes 169,997 177,470 Accrued lease liability 1,061,597 266,212 Total liabilities 2,509,467 2,019,597 Commitments and contingencies (Note 4) — — Shareholders' equity: Preferred stock, no par value: 10,000,000 shares authorized; none issued and outstanding — — Common stock and additional paid-in capital, no par value: 100,000,000 shares authorized; 11,879,645 and 11,879,645 issued and outstanding at June 30, 2025, and March 31, 2025, respectively 24,428,466 24,416,347 Accumulated (deficit) ( 22,806,378 ) ( 22,765,245 ) Total shareholders' equity 1,622,088 1,651,102 TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 4,131,555 $ 3,670,699 The accompanying notes to financial statements are an integral part of these unaudited condensed financial statements. 1 Encision Inc. Condensed Statements of Operations (Unaudited) Three Mo

View Full Filing

View this 10-Q filing on SEC EDGAR